Skip to content

Clinical trials

Phase 2 Lupus Erythematosus, Systemic trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lupus Erythematosus, Systemic Phase: Phase 2 Country / region: Japan Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20123
20131
20161
20172
20182
20194
20203
20212
20222
20231
20242
20251
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Active, not recruiting6
Recruiting3
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
AbbVie2
Bristol-Myers Squibb2
EMD Serono Research & Development Institute, Inc.2
GlaxoSmithKline2
Novartis Pharmaceuticals2
Amgen1
Beeline Medicines Corporation1
Boehringer Ingelheim1
EMD Serono1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lupus Erythematosus, Systemic28
Autoimmune Diseases2
Connective Tissue Diseases2
Immune System Diseases2
Lupus Erythematosus, Cutaneous2
Lupus Erythematosus, Discoid2
Lupus Nephritis2
Mycobacterium Infections, Nontuberculous1

Trials

Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.